Evidence map›Paper›PMID 34201794›Full record

ReviewMarine drugs2021

Seaweed Components as Potential Modulators of the Gut Microbiota.

Emer Shannon, Michael Conlon, Maria Hayes

Open access · goldAbstract readReview
In one paragraph

Review in Marine drugs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
20.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 138 citations in OpenAlex.

  1. The Effect ofNutrients · 2024
    Trial
  2. Trial
  3. Trial
  4. DietaryAnimals : an open access journal from MDPI · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Dietary Green-AlgaeAnimals : an open access journal from MDPI · 2026
    Article
  9. Article
  10. From Sea to Sweet: Seaweed's Role in Nutritious and Sustainable Confectionery.Comprehensive reviews in food science and food safety · 2026
    Review
  11. Article
  12. Review
  13. The antihyperglycemic potential ofFood science and biotechnology · 2025
    Article
  14. Review
  15. Article
  16. Review
  17. Role ofMarine drugs · 2025
    Article
  18. Article
  19. Article
  20. Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Emer ShannonFood Biosciences, Teagasc Food Research Centre, Ashtown, D15 KN3K Dublin, Ireland.ORCID 0000-0002-8663-3110
Michael ConlonCSIRO Health and Biosecurity, Kintore Avenue, Adelaide, SA 5000, Australia.
Maria HayesFood Biosciences, Teagasc Food Research Centre, Ashtown, D15 KN3K Dublin, Ireland.
Teagasc - The Irish Agriculture and Food Development Authority · IECSIRO Health and Biosecurity · AU

Funding

H2020 Marie Skłodowska-Curie Actions 75438
6 · The paper itself

Abstract

Macroalgae, or seaweeds, are a rich source of components which may exert beneficial effects on the mammalian gut microbiota through the enhancement of bacterial diversity and abundance. An imbalance of gut bacteria has been linked to the development of disorders such as inflammatory bowel disease, immunodeficiency, hypertension, type-2-diabetes, obesity, and cancer. This review outlines current knowledge from

Indexed as

Gastrointestinal MicrobiomeSeaweedAquatic OrganismsHumansPrebioticsPrebioticsbioaccessibilitycolonic fermentationgut microbiotapeptidespolyphenolspolysaccharidesprebioticsseaweedshort chain fatty acidssimulated gastrointestinal and fermentation digestion models

Identifiers

PMID34201794
PMCPMC8303941
OpenAlexW3176881763

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.